RecruitingNot ApplicableNCT07060378

A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes

Sponsor

Shanghai Chest Hospital

Enrollment

250 participants

Start Date

Jul 10, 2025

Study Type

INTERVENTIONAL

Conditions

Lung Lesions Mediastinal and Hilar Lymph Node Enlargement

Summary

Exploring the Clinical Application Value of Contrast Enhancement Features in CE-EBUS Images for the Diagnosis of Pulmonary Lesions and Intrapulmonary Lymph Nodes

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Contrast-enhanced endobronchial ultrasound for people with lung lesions and mediastinal and hilar lymph node enlargement. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEContrast-enhanced endobronchial ultrasound

Using CE-EBUS to observe pulmonary lesions and abnormal enlarged intrathoracic lymph nodes, the enhancement characteristics of benign and malignant lesions under CE-EBUS were extracted for both conditions.

Locations(1)

Shanghai Chest Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07060378

Related Trials

Robotic-assisted Bronchoscopy Under Moderate Sedation With Propofol

NCT070063111 location